BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21663454)

  • 1. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
    Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
    DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
    Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
    Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
    Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
    Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
    J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells.
    Rooney S; Alt FW; Lombard D; Whitlow S; Eckersdorff M; Fleming J; Fugmann S; Ferguson DO; Schatz DG; Sekiguchi J
    J Exp Med; 2003 Mar; 197(5):553-65. PubMed ID: 12615897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.
    Multhaup M; Karlen AD; Swanson DL; Wilber A; Somia NV; Cowan MJ; McIvor RS
    Hum Gene Ther; 2010 Jul; 21(7):865-75. PubMed ID: 20163250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of transduction efficiency among various lentiviruses containing GFP reporter in bone marrow hematopoietic stem cell transplantation.
    Wang N; Rajasekaran N; Hou T; Lisowski L; Mellins ED
    Exp Hematol; 2013 Nov; 41(11):934-43. PubMed ID: 23954710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
    Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
    Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.
    Jacobs C; Huang Y; Masud T; Lu W; Westfield G; Giblin W; Sekiguchi JM
    Hum Mol Genet; 2011 Feb; 20(4):806-19. PubMed ID: 21147755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced immunoglobulin class switch recombination in the absence of Artemis.
    Rivera-Munoz P; Soulas-Sprauel P; Le Guyader G; Abramowski V; Bruneau S; Fischer A; Pâques F; de Villartay JP
    Blood; 2009 Oct; 114(17):3601-9. PubMed ID: 19692705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
    Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
    Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
    Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP
    Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphopoiesis in transgenic mice over-expressing Artemis.
    Rivera-Munoz P; Abramowski V; Jacquot S; André P; Charrier S; Lipson-Ruffert K; Fischer A; Galy A; Cavazzana M; de Villartay JP
    Gene Ther; 2016 Feb; 23(2):176-86. PubMed ID: 26361272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.
    van der Burg M; Ijspeert H; Verkaik NS; Turul T; Wiegant WW; Morotomi-Yano K; Mari PO; Tezcan I; Chen DJ; Zdzienicka MZ; van Dongen JJ; van Gent DC
    J Clin Invest; 2009 Jan; 119(1):91-8. PubMed ID: 19075392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemis deficiency confers a DNA double-strand break repair defect and Artemis phosphorylation status is altered by DNA damage and cell cycle progression.
    Wang J; Pluth JM; Cooper PK; Cowan MJ; Chen DJ; Yannone SM
    DNA Repair (Amst); 2005 May; 4(5):556-70. PubMed ID: 15811628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
    Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of G1 chemo/radioresistance and double-strand-break repair proficiency by wild-type but not endonuclease-deficient Artemis.
    Mohapatra S; Kawahara M; Khan IS; Yannone SM; Povirk LF
    Nucleic Acids Res; 2011 Aug; 39(15):6500-10. PubMed ID: 21531702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.